Literature DB >> 22991350

Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.

Tanya N Turan1, Michael J Lynn, Azhar Nizam, Bethany Lane, Brent M Egan, Ngoc-Anh Le, Maria F Lopes-Virella, Kathie L Hermayer, Oscar Benavente, Carole L White, W Virgil Brown, Michelle F Caskey, Meghan R Steiner, Nicole Vilardo, Andrew Stufflebean, Colin P Derdeyn, David Fiorella, Scott Janis, Marc I Chimowitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22991350      PMCID： PMC3500085          DOI： 10.1161/CIRCOUTCOMES.112.966911

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  43 in total

Review 1.  Pleiotropic effects of statins.

Authors:  James K Liao; Ulrich Laufs
Journal:  Annu Rev Pharmacol Toxicol       Date:  2005       Impact factor: 13.820

2.  Standards of medical care in diabetes--2006.

Authors: 
Journal:  Diabetes Care       Date:  2006-01       Impact factor: 19.112

3.  Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

Authors:  B Pitt; D Waters; W V Brown; A J van Boven; L Schwartz; L M Title; D Eisenberg; L Shurzinske; L S McCormick
Journal:  N Engl J Med       Date:  1999-07-08       Impact factor: 91.245

Review 4.  The treatment gap in coronary artery disease and heart failure: community standards and the post-discharge patient.

Authors:  T A Pearson; T D Peters
Journal:  Am J Cardiol       Date:  1997-10-30       Impact factor: 2.778

5.  Inadequate treatment with HMG-CoA reductase inhibitors by health care providers.

Authors:  J J Marcelino; K R Feingold
Journal:  Am J Med       Date:  1996-06       Impact factor: 4.965

6.  Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia.

Authors:  Neil F Gordon; Richard D Salmon; Barry A Franklin; Laurence S Sperling; Linda Hall; Richard F Leighton; William L Haskell
Journal:  Am J Cardiol       Date:  2004-12-15       Impact factor: 2.778

Review 7.  Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism.

Authors:  Paul Poirier; Thomas D Giles; George A Bray; Yuling Hong; Judith S Stern; F Xavier Pi-Sunyer; Robert H Eckel
Journal:  Circulation       Date:  2005-12-27       Impact factor: 29.690

8.  Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial.

Authors:  Kausik K Ray; Christopher P Cannon; Carolyn H McCabe; Richard Cairns; Andrew M Tonkin; Frank M Sacks; Graham Jackson; Eugene Braunwald
Journal:  J Am Coll Cardiol       Date:  2005-10-18       Impact factor: 24.094

9.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline.

Authors:  Ralph L Sacco; Robert Adams; Greg Albers; Mark J Alberts; Oscar Benavente; Karen Furie; Larry B Goldstein; Philip Gorelick; Jonathan Halperin; Robert Harbaugh; S Claiborne Johnston; Irene Katzan; Margaret Kelly-Hayes; Edgar J Kenton; Michael Marks; Lee H Schwamm; Thomas Tomsick
Journal:  Circulation       Date:  2006-03-14       Impact factor: 29.690

10.  Endarterectomy for asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.

Authors: 
Journal:  JAMA       Date:  1995-05-10       Impact factor: 56.272
View more
  26 in total

1.  Practical approach to management of intracranial atherosclerosis.

Authors:  Jessica Hannah; Shelly Ozark; Tanya N Turan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-03

Review 2.  Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.

Authors:  Chirantan Banerjee; Marc I Chimowitz
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

3.  Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.

Authors:  Colin P Derdeyn; David Fiorella; Michael J Lynn; Zoran Rumboldt; Harry J Cloft; Daniel Gibson; Tanya N Turan; Bethany F Lane; L Scott Janis; Marc I Chimowitz
Journal:  Neurosurgery       Date:  2013-05       Impact factor: 4.654

4.  Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis?

Authors:  Tanya N Turan; Alison Smock; George Cotsonis; David Bachman; Sami Al Kasab; Michael J Lynn; Azhar Nizham; Collin P Derdeyn; David Fiorella; Scott Janis; Bethany Lane; Jean Montgomery; Marc I Chimowitz
Journal:  Cerebrovasc Dis       Date:  2016-11-05       Impact factor: 2.762

5.  Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?

Authors:  Helmi L Lutsep; Michael J Lynn; George A Cotsonis; Colin P Derdeyn; Tanya N Turan; David Fiorella; L Scott Janis; Bethany F Lane; Jean Montgomery; Marc I Chimowitz
Journal:  Stroke       Date:  2015-09-17       Impact factor: 7.914

6.  Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.

Authors:  Tanya N Turan; George Cotsonis; Michael J Lynn; Rahim H Wooley; Seegar Swanson; Janice E Williams; Barney J Stern; Colin P Derdeyn; David Fiorella; Marc I Chimowitz
Journal:  Cerebrovasc Dis       Date:  2014-02-19       Impact factor: 2.762

7.  Rationale, Design, and Implementation of Intensive Risk Factor Treatment in the CREST2 Trial.

Authors:  Tanya N Turan; Jenifer H Voeks; Marc I Chimowitz; Ana Roldan; Todd LeMatty; William Haley; Maria Lopes-Virella; Seemant Chaturvedi; Michael Jones; Donald Heck; George Howard; Brajesh K Lal; James F Meschia; Thomas G Brott
Journal:  Stroke       Date:  2020-09-21       Impact factor: 7.914

Review 8.  Management of Symptomatic Intracranial Stenosis.

Authors:  David A Hoak; Helmi L Lutsep
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

9.  Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?

Authors:  Seemant Chaturvedi; Tanya N Turan; Michael J Lynn; Colin P Derdeyn; David Fiorella; L Scott Janis; Marc I Chimowitz
Journal:  Stroke       Date:  2015-08-06       Impact factor: 7.914

10.  Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.

Authors:  Michael F Waters; Brian L Hoh; Michael J Lynn; Hyung-Min Kwon; Tanya N Turan; Colin P Derdeyn; David Fiorella; Anna Khanna; Tiffany O Sheehan; Bethany F Lane; Scott Janis; Jean Montgomery; Marc I Chimowitz
Journal:  JAMA Neurol       Date:  2016-03       Impact factor: 18.302
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.